False Lancet study
This article was originally published in The Tan Sheet
Executive Summary
The Lancet has "received confirmation" that a study published by the journal in October on NSAIDs and reduction of oral cancer contains fabricated data, the publication announces Feb. 4. The false data was provided by lead author John Sudbo, MD/PhD, Norwegian Radium Hospital. The journal's editors released an "expression of concern" about the fabricated data Jan. 17 when they were first alerted to the problem (1"The Tan Sheet" Jan. 23, 2005, In Brief)...
You may also be interested in...
Lancet study a sham?
Editors of The Lancet issued an "expression of concern" Jan. 17 about a study published in the journal in October which appeared to be based on "complete fabrication" by the study's lead author. John Sudbo, MD, PhD, Norwegian Radium Hospital, et al., found in a study that long-term use of NSAIDs was linked to reduced incidence of oral cancer but increased risk of death from cardiovascular disease. The hospital alerted Lancet editors to the problem Jan. 13, and the publication states that "the journal has not yet received written confirmation...that fabrication actually took place." The hospital has appointed an investigation committee to look into the matter. Sudbo's findings were first presented at the American Association for Cancer Research annual meeting in April (1"The Tan Sheet" April 25, 2005, p. 10)...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.